Ticker Report Research analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) in a report issued on Saturday. The brokerage set a "hold" rating on the...\n more…
Ticker Report StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) in a research report issued on Friday. The firm set a "hold" rating on the specialty...\n more…
Ticker Report StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX - Free Report) in a report issued on Thursday. The firm issued a hold rating on the specialty pharmaceutical...\n more…
Ticker Report Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 15,500 shares, a...\n more…
Ticker Report Research analysts at StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) in a research report issued on Wednesday. The brokerage set a "hold" rating...\n more…